Identification of the cytochrome P-450 induced by macrolide antibiotics in rat liver as the glucocorticoid responsive cytochrome P-450p

This article is cited by 247 publications.

1. Nao Torimoto,, Itsuko Ishii,, Masayuki Hata,, Hiroyoshi Nakamura,, Hiroshi Imada,, Noritaka Ariyoshi,, Shigeru Ohmori,, Takashi Igarashi, and, Mitsukazu Kitada. Direct Interaction between Substrates and Endogenous Steroids in the Active Site May Change the Activity of Cytochrome P450 3A4. Biochemistry 2003, 42 (51) , 15068-15077. https://doi.org/10.1021/bi034409n
2. K. R. Korzekwa,, N. Krishnamachary,, M. Shou,, A. Ogai,, R. A. Parise,, A. E. Rettie,, F. J. Gonzalez, and, T. S. Tracy. Evaluation of Atypical Cytochrome P450 Kinetics with Two-Substrate Models:  Evidence That Multiple Substrates Can Simultaneously Bind to Cytochrome P450 Active Sites. Biochemistry 1998, 37 (12) , 4137-4147. https://doi.org/10.1021/bi9715627
3. Waranya Chatuphonprasert, Yollada Sriset, Kanokwan Jarukamjorn. Continuous Consumption of Reused Palm Oil Induced Hepatic Injury, Depletion of Glutathione Stores, and Modulation of Cytochrome P450 Profiles in Mice. Polish Journal of Food and Nutrition Sciences 2019, 69 (1) , 53-61. https://doi.org/10.31883/pjfns-2019-0009
4. María-Aránzazu Martínez, Irma Ares, Jose-Luís Rodríguez, Marta Martínez, María-Rosa Martínez-Larrañaga, Arturo Anadón. Induction of cytochrome P450-dependent mixed function oxidase activities and peroxisome proliferation by chloramine-T in male rat liver. Food and Chemical Toxicology 2017, 106 , 86-91. https://doi.org/10.1016/j.fct.2017.05.012
5. Olga B. Tseilikman, Denis A. Kozochkin, Eugenia B. Manukhina, H. Fred Downey, Maria E. Misharina, Maria V. Komelkova, Anna A. Nikitina, Svyatoslav V. Golodnii, Margarita A. Dodohova, Vadim E. Tseilikman. Predicting anxiety responses to halogenated glucocorticoid drugs using the hexobarbital sleep time test. Stress 2016, 19 (4) , 390-394. https://doi.org/10.1080/10253890.2016.1183118
6. M. Farooq, E. J. Kelly, J. D. Unadkat. CYP2D6 Is Inducible by Endogenous and Exogenous Corticosteroids. Drug Metabolism and Disposition 2016, 44 (5) , 750-757. https://doi.org/10.1124/dmd.115.069229
7. M.V. Caballero, I. Ares, M. Martínez, M.R. Martínez-Larrañaga, A. Anadón, M.A. Martínez. Fipronil induces CYP isoforms in rats. Food and Chemical Toxicology 2015, 83 , 215-221. https://doi.org/10.1016/j.fct.2015.06.019
8. Maria Almira Correia, Paul. F. Hollenberg. Inhibition of Cytochrome P450 Enzymes. 2015, 177-259. https://doi.org/10.1007/978-3-319-12108-6_5
9. A. Anadón, M.A. Martínez, M. Martínez, V. Castellano, I. Ares, A. Romero, R. Fernández, M.R. Martínez-Larrañaga. Differential induction of cytochrome P450 isoforms and peroxisomal proliferation by cyfluthrin in male Wistar rats. Toxicology Letters 2013, 220 (2) , 135-142. https://doi.org/10.1016/j.toxlet.2013.04.015
10. Jehan A Khan, Jalaluddin A Jalal, C Ioanndes, Said S Moselhy. Evaluation of the in vitro antimutagenic effect of Doash tea aqueous extracts. Toxicology and Industrial Health 2012, 28 (7) , 593-604. https://doi.org/10.1177/0748233711416952
11. Adaweyah El-Merhibi, Suong N.T. Ngo, Tamara A. Crittenden, Ceilidh L. Marchant, Ieva Stupans, Ross A. McKinnon. Cytochrome P450 CYP3A in marsupials: Cloning and characterisation of the second identified CYP3A subfamily member, isoform 3A78 from koala (Phascolarctos cinereus). Comparative Biochemistry and Physiology Part C: Toxicology & Pharmacology 2011, 154 (4) , 367-376. https://doi.org/10.1016/j.cbpc.2011.07.007
12. Adaweyah El-Merhibi, Suong N.T. Ngo, Ceilidh L. Marchant, Tamara A. Height, Ieva Stupans, Ross A. McKinnon. WITHDRAWN: Cytochrome P450 CYP3A in marsupials: Characterisation of the first identified CYP3A subfamily member, isoform 3A70 from Eastern grey kangaroo (Macropus giganteus). Gene 2011, 14 https://doi.org/10.1016/j.gene.2011.06.036
13. Massimo Valoti, Maria Frosini, Mitri Palmi, Francesco de Matteis, Gianpietro Sgaragli. N -Dealkylation of Chlorimipramine and Chlorpromazine by Rat Liver Microsomal Cytochrome P450 Isoenzymes. Journal of Pharmacy and Pharmacology 2011, 50 (9) , 1005-1011. https://doi.org/10.1111/j.2042-7158.1998.tb06915.x
14. Soo Kyung Bae, Shin Jung Lee, Young Hoon Kim, Taekrho Kim, Myung Gull Lee. Effect of enzyme inducers and inhibitors on the pharmacokinetics of oltipraz in rats. Journal of Pharmacy and Pharmacology 2010, 57 (4) , 443-452. https://doi.org/10.1211/0022357055704
15. B Baune, J P Flinois, V Furlan, F Gimenez, A M Taburet, L Becquemont, R Farinotti. Halofantrine Metabolism in Microsomes in Man: Major Role of CYP 3A4 and CYP 3A5. Journal of Pharmacy and Pharmacology 2010, 51 (4) , 419-426. https://doi.org/10.1211/0022357991772628
16. Hye J Chung, Young H Choi, Myung G Lee, So H Kim. Effects of enzyme inducers and inhibitors on the pharmacokinetics of intravenous ipriflavone in rats. Journal of Pharmacy and Pharmacology 2010, 58 (4) , 449-457. https://doi.org/10.1211/jpp.58.4.0004
17. Kyung H Yang, Joo H Lee, Myung G Lee. Effects of CYP inducers and inhibitors on the pharmacokinetics of intravenous theophylline in rats: involvement of CYP1A1/2 in the formation of 1,3-DMU. Journal of Pharmacy and Pharmacology 2010, 60 (1) , 45-53. https://doi.org/10.1211/jpp.60.1.0006
18. Si H Yang, Myung G Lee. Effects of cytochrome P450 (CYP) inducers and inhibitors on ondansetron pharmacokinetics in rats: involvement of hepatic CYP2D subfamily and 3A1/2 in ondansetron metabolism. Journal of Pharmacy and Pharmacology 2010, 60 (7) , 853-861. https://doi.org/10.1211/jpp.60.7.0006
19. Ayyasamy Manimaran, Souvendra Nath Sarkar, Palanisamy Sankar. Influence of repeated preexposure to arsenic on acetaminophen-induced oxidative stress in liver of male rats. Food and Chemical Toxicology 2010, 48 (2) , 605-610. https://doi.org/10.1016/j.fct.2009.11.039
20. Kyung H Yang, Young H Choi, Unji Lee, Joo H Lee, Myung G Lee. Effects of cytochrome P450 inducers and inhibitors on the pharmacokinetics of intravenous furosemide in rats: involvement of CYP2C11, 2E1, 3A1 and 3A2 in furosemide metabolism. Journal of Pharmacy and Pharmacology 2010, 61 (1) , 47-54. https://doi.org/10.1211/jpp.61.01.0007
21. Ayyasamy Manimaran, Souvendra Nath Sarkar, Palanisamy Sankar. Toxicodynamics of subacute co-exposure to groundwater contaminant arsenic and analgesic–antipyretic drug acetaminophen in rats. Ecotoxicology and Environmental Safety 2010, 73 (1) , 94-100. https://doi.org/10.1016/j.ecoenv.2009.09.005
22. Magang Shou, Anthony Y. H. Lu. Antibodies as a Probe in Cytochrome P450 Research. Drug Metabolism and Disposition 2009, 37 (5) , 925-931. https://doi.org/10.1124/dmd.108.025718
23. Lionel Perrin, Caroline Aninat, Véronique Hamon, Yoshio Hayashi, Catherine Abadie, Bruno Heyd, François André, Marcel Delaforge. Metabolism of Phenylahistin Enantiomers by Cytochromes P450: A Possible Explanation for Their Different Cytotoxicity. Drug Metabolism and Disposition 2008, 36 (11) , 2381-2392. https://doi.org/10.1124/dmd.107.019919
24. Kristina K. Wolf, Sheryl G. Wood, Jenna L. Allard, Jane A. Hunt, Nadia Gorman, Brooke W. Walton-Strong, Juliana G. Szakacs, Su X. Duan, Qin Hao, Michael H. Court, Lisa L. von Moltke, David J. Greenblatt, Vsevolod Kostrubsky, Elizabeth H. Jeffery, Steven A. Wrighton, Frank J. Gonzalez, Peter R. Sinclair, Jacqueline F. Sinclair. Role of CYP3A and CYP2E1 in Alcohol-Mediated Increases in Acetaminophen Hepatotoxicity: Comparison of Wild-Type and Cyp2e1 (–/–) Mice. Drug Metabolism and Disposition 2007, 35 (7) , 1223-1231. https://doi.org/10.1124/dmd.107.014738
25. Joo H. Lee, Myung G. Lee. Effects of acute renal failure on the pharmacokinetics of telithromycin in rats: negligible effects of increase in CYP3A1 on the metabolism of telithromycin. Biopharmaceutics & Drug Disposition 2007, 28 (4) , 157-166. https://doi.org/10.1002/bdd.542
26. Nobuyuki Koga, Miki Matsuo, Chiho Ohta, Koichi Haraguchi, Mikiko Matsuoka, Yoshihisa Kato, Toshinao Ishii, Masamichi Yano, Hideaki Ohta. Comparative Study on Nobiletin Metabolism with Liver Microsomes from Rats, Guinea Pigs and Hamsters and Rat Cytochrome P450. Biological and Pharmaceutical Bulletin 2007, 30 (12) , 2317-2323. https://doi.org/10.1248/bpb.30.2317
27. Venkata Ramesh Dasari, Hindupur K. Anandatheerthavarada, Marie-Anne Robin, Ettickan Boopathi, Gopa Biswas, Ji-Kang Fang, Daniel W. Nebert, Narayan G. Avadhani. Role of Protein Kinase C-mediated Protein Phosphorylation in Mitochondrial Translocation of Mouse CYP1A1, Which Contains a Non-canonical Targeting Signal. Journal of Biological Chemistry 2006, 281 (41) , 30834-30847. https://doi.org/10.1074/jbc.M510725200
28. Y H Choi, M G Lee. Effects of enzyme inducers and inhibitors on the pharmacokinetics of metformin in rats: involvement of CYP2C11, 2D1 and 3A1/2 for the metabolism of metformin. British Journal of Pharmacology 2006, 149 (4) , 424-430. https://doi.org/10.1038/sj.bjp.0706875
29. Dae Y. Lee, Hyun S. Shin, Soo K. Bae, Myung G. Lee. Effects of enzyme inducers and inhibitors on the pharmacokinetics of intravenous omeprazole in rats. Biopharmaceutics & Drug Disposition 2006, 27 (5) , 209-218. https://doi.org/10.1002/bdd.502
30. Joo H. Lee, Eun J. Kim, Jong W. Kwon, Moohi Yoo, Myung G. Lee. Negligible pharmacokinetic interaction between oral DA-8159, a new erectogenic, and amlodipine in rats. Biopharmaceutics & Drug Disposition 2006, 27 (3) , 125-131. https://doi.org/10.1002/bdd.491
31. Jasminder Sahi, Michael W. Sinz, Scott Campbell, Rouchelle Mireles, Xianxian Zheng, Kelly A. Rose, Shamsi Raeissi, Muhammed F. Hashim, Yuyang Ye, Sonia M. de Morais, Christopher Black, Meera Tugnait, Laurence H. Keller. Metabolism and transporter-mediated drug–drug interactions of the endothelin-A receptor antagonist CI-1034. Chemico-Biological Interactions 2006, 159 (2) , 156-168. https://doi.org/10.1016/j.cbi.2005.11.001
32. Victoria Yoxall, Peter Kentish, Nick Coldham, Nikolai Kuhnert, Maurice J. Sauer, Costas Ioannides. Modulation of hepatic cytochromes P450 and phase II enzymes by dietary doses of sulforaphane in rats: Implications for its chemopreventive activity. International Journal of Cancer 2005, 117 (3) , 356-362. https://doi.org/10.1002/ijc.21191
33. Yu C. Kim, Hyun J. Shim, Joo H. Lee, Soon H. Kim, Jong W. Kwon, Won B. Kim, Myung G. Lee. Effects of enzyme inducers and inhibitors on the pharmacokinetics of intravenous DA‐8159, a new erectogenic, in rats. Biopharmaceutics & Drug Disposition 2005, 26 (6) , 233-241. https://doi.org/10.1002/bdd.453
34. Dae Y. Lee, Shin J. Lee, Myung G. Lee. Effects of enzyme inducers and inhibitors on the pharmacokinetics of intravenous torasemide in rats. International Journal of Pharmaceutics 2005, 298 (1) , 38-46. https://doi.org/10.1016/j.ijpharm.2005.03.014
35. Richard C. Zangar .. Alterations in Hepatic Cholesterol Levels in Response to Drugs That Induce Cytochrome P450 3A23. International Journal of Pharmacology 2005, 1 (2) , 172-179. https://doi.org/10.3923/ijp.2005.172.179
36. Jasminder Sahi, Ralph H. Stern, Mark A. Milad, Kelly A. Rose, Gordon Gibson, Xianxian Zheng, Linda Stilgenbauer, Nalini Sadagopan, Summer Jolley, Darryl Gilbert, Edward L. LeCluyse. EFFECTS OF AVASIMIBE ON CYTOCHROME P450 2C9 EXPRESSION IN VITRO AND IN VIVO. Drug Metabolism and Disposition 2004, 32 (12) , 1370-1376. https://doi.org/10.1124/dmd.104.000208
37. Yuzhong Ma, Karuna Sachdeva, Jirong Liu, Michael Ford, Dongfang Yang, Ikhlas A. Khan, Clinton O. Chichester, Bingfang Yan. DESMETHOXYYANGONIN AND DIHYDROMETHYSTICIN ARE TWO MAJOR PHARMACOLOGICAL KAVALACTONES WITH MARKED ACTIVITY ON THE INDUCTION OF CYP3A23. Drug Metabolism and Disposition 2004, 32 (11) , 1317-1324. https://doi.org/10.1124/dmd.104.000786
38. Ae K. Lee, Joo H. Lee, Jong W. Kwon, Won B. Kim, Sang G. Kim, So H. Kim, Myung G. Lee. Pharmacokinetics of clarithromycin in rats with acute renal failure induced by uranyl nitrate. Biopharmaceutics & Drug Disposition 2004, 25 (6) , 273-282. https://doi.org/10.1002/bdd.409
39. Joo Hyun Lee, Ok Kyung Suh, Myung Gull Lee. Pharmacokinetic changes in drugs during protein-calorie malnutrition: correlation between drug metabolism and hepatic microsomal cytochrome p450 isozymes. Archives of Pharmacal Research 2004, 27 (7) https://doi.org/10.1007/BF02980136
40. Jasminder Sahi, Mark A. Milad, Xianxian Zheng, Kelly A. Rose, Hongbing Wang, Linda Stilgenbauer, Darryl Gilbert, Summer Jolley, Ralph H. Stern, Edward L. LeCluyse. Avasimibe Induces CYP3A4 and Multiple Drug Resistance Protein 1 Gene Expression through Activation of the Pregnane X Receptor. Journal of Pharmacology and Experimental Therapeutics 2003, 306 (3) , 1027-1034. https://doi.org/10.1124/jpet.103.050526
41. F. Catterall, N.J. McArdle, L. Mitchell, A. Papayanni, M.N. Clifford, C. Ioannides. Hepatic and intestinal cytochrome P450 and conjugase activities in rats treated with black tea theafulvins and theaflavins. Food and Chemical Toxicology 2003, 41 (8) , 1141-1147. https://doi.org/10.1016/S0278-6915(03)00073-5
42. R. Walter, C. Ullmann, D. Thümmler, W. Siegmund. INFLUENCE OF PROPIVERINE ON HEPATIC MICROSOMAL CYTOCHROME P450 ENZYMES IN MALE RATS. Drug Metabolism and Disposition 2003, 31 (6) , 714-717. https://doi.org/10.1124/dmd.31.6.714
43. Makiko Shimizu, Reiko Matsushita, Yoshiaki Matsumoto, Masamichi Fukuoka. 4'-Hydroxylation of Flurbiprofen by Rat Liver Microsomes in Fasting and Feeding Conditions. Biological and Pharmaceutical Bulletin 2003, 26 (10) , 1448-1454. https://doi.org/10.1248/bpb.26.1448
44. Steven A. Kliewer, Bryan Goodwin, Timothy M. Willson. The Nuclear Pregnane X Receptor: A Key Regulator of Xenobiotic Metabolism. Endocrine Reviews 2002, 23 (5) , 687-702. https://doi.org/10.1210/er.2001-0038
45. Yuan Hua Wen, Jasminder Sahi, Ellen Urda, Shaila Kulkarni, Kelly Rose, Xianxian Zheng, Jacqueline F. Sinclair, Hongbo Cai, Stephen C. Strom, Vsevolod E. Kostrubsky. Effects of Bergamottin on Human and Monkey Drug-Metabolizing Enzymes in Primary Cultured Hepatocytes. Drug Metabolism and Disposition 2002, 30 (9) , 977-984. https://doi.org/10.1124/dmd.30.9.977
46. Tsutomu Sakuma, Yusuke Endo, Misae Mashino, Masami Kuroiwa, Ayako Ohara, Kanokwan Jarukamjorn, Nobuo Nemoto. Regulation of the expression of two female-predominant CYP3A mRNAs (CYP3A41 and CYP3A44) in mouse liver by sex and growth hormones. Archives of Biochemistry and Biophysics 2002, 404 (2) , 234-242. https://doi.org/10.1016/S0003-9861(02)00329-6
47. Alf H. Haukenes, Christine M. Moffitt. Hatchery Evaluation of Erythromycin Phosphate Injections in Prespawning Spring Chinook Salmon. North American Journal of Aquaculture 2002, 64 (3) , 167-174. https://doi.org/10.1577/1548-8454(2002)064<0167:HEOEPI>2.0.CO;2
48. Hiroki Shimada, Hidenori Furuno, Kei-Ichi Hirai, Junko Koyama, Jun Ariyama, Eriko Simamura. Paraquat detoxicative system in the mouse liver postmitochondrial fraction. Archives of Biochemistry and Biophysics 2002, 402 (1) , 149-157. https://doi.org/10.1016/S0003-9861(02)00059-0
49. Bryan Goodwin, Matthew R. Redinbo, Steven A. Kliewer. Regulation of CYP3A Gene Transcription by the Pregnane X Receptor. Annual Review of Pharmacology and Toxicology 2002, 42 (1) , 1-23. https://doi.org/10.1146/annurev.pharmtox.42.111901.111051
50. D.E. Feierman, Z. Melnikov, J. Zhang. The Paradoxical Effect of Acetaminophen on CYP3A4 Activity and Content in Transfected HepG2 Cells. Archives of Biochemistry and Biophysics 2002, 398 (1) , 109-117. https://doi.org/10.1006/abbi.2001.2677
51. Jasminder Sahi, Eric L. Reyner, Jonathan N. Bauman, Kristina Gueneva-Boucheva, James E. Burleigh, V. Hayden Thomas. The Effect of Bergamottin on Diazepam Plasma Levels and P450 Enzymes in Beagle Dogs. Drug Metabolism and Disposition 2002, 30 (2) , 135-140. https://doi.org/10.1124/dmd.30.2.135
52. Yasuna Kobayashi, Michiya Suzuki, Naomi Ohshiro, Takashi Sunagawa, Tadanori Sasaki, Takiko Oguro, Shogo Tokuyama, Toshinori Yamamoto, Takemi Yoshida. Induction and Inhibition of Cytochrome P450 and Drug-Metabolizing Enzymes by Climbazole.. Biological and Pharmaceutical Bulletin 2002, 25 (1) , 53-57. https://doi.org/10.1248/bpb.25.53
53. Susila Sivapathasundaram, Paraskevi Magnisali, Nick G. Coldham, Laurence C. Howells, Maurice J. Sauer, Costas Ioannides. A study of the expression of the xenobiotic-metabolising cytochrome P450 proteins and of testosterone metabolism in bovine liver. Biochemical Pharmacology 2001, 62 (5) , 635-645. https://doi.org/10.1016/S0006-2952(01)00710-9
54. Holger Rosenbrock, Christoph E. Hagemeyer, Margarethe Ditter, Rolf Knoth, Benedict Volk. Identification, induction and localization of cytochrome P450s of the 3A-subfamily in mouse brain. Neurotoxicity Research 2001, 3 (4) , 339-349. https://doi.org/10.1007/BF03033195
55. Alain Berson, Daniel Fau, Roxane Fornacciari, Pamela Degove-Goddard, Angela Sutton, Véronique Descatoire, Delphine Haouzi, Philippe Lettéron, Alain Moreau, Gérard Feldmann, Dominique Pessayre. Mechanisms for experimental buprenorphine hepatotoxicity: major role of mitochondrial dysfunction versus metabolic activation. Journal of Hepatology 2001, 34 (2) , 261-269. https://doi.org/10.1016/S0168-8278(00)00050-7
56. P. Kozlik, H. R. Ha, B. Stieger, L. Bigler, F. Follath. Metabolism of amiodarone (Part III): identification of rabbit cytochrome P450 isoforms involved in the hydroxylation of mono- N -desethylamiodarone. Xenobiotica 2001, 31 (5) , 239-248. https://doi.org/10.1080/00498250110046442
57. Quan Zhou. Chiral metabolism of propafenone in rat hepatic microsomes treated with two inducers. World Journal of Gastroenterology 2001, 7 (6) , 830. https://doi.org/10.3748/wjg.v7.i6.830
58. Ding Dai, Re Bai, Ernest Hodgson, Randy L. Rose. Cloning, sequencing, heterologous expression, and characterization of murine cytochrome P450 3a25*(Cyp3a25), a testosterone 6β‐hydroxylase. Journal of Biochemical and Molecular Toxicology 2001, 15 (2) , 90-99. https://doi.org/10.1002/jbt.4
59. Delphine Haouzi, Mounia Lekéhal, Alain Moreau, Claude Moulis, Gérard Feldmann, Marie-Anne Robin, Philippe Lettéron, Daniel Fau, Dominique Pessayre. Cytochrome P450–generated reactive metabolites cause mitochondrial permeability transition, caspase activation, and apoptosis in rat hepatocytes. Hepatology 2000, 32 (2) , 303-311. https://doi.org/10.1053/jhep.2000.9034
60. Tsutomu Sakuma, Masae Takai, Yusuke Endo, Masami Kuroiwa, Ayako Ôhara, Kanokwan Jarukamjorn, Rieko Honma, Nobuo Nemoto. A Novel Female-Specific Member of the CYP3A Gene Subfamily in the Mouse Liver. Archives of Biochemistry and Biophysics 2000, 377 (1) , 153-162. https://doi.org/10.1006/abbi.2000.1747
61. Edward L. LeCluyse, Ajay Madan, Geraldine Hamilton, Kathy Carroll, Ryan DeHaan, Andrew Parkinson. Expression and regulation of cytochrome P450 enzymes in primary cultures of human hepatocytes. Journal of Biochemical and Molecular Toxicology 2000, 14 (4) , 177-188. https://doi.org/10.1002/(SICI)1099-0461(2000)14:4<177::AID-JBT1>3.0.CO;2-4
62. Eva Hadašová, Zuzana Charvátová, Kateřina Nerušilová, Marie Hyksová, Olga Zelenková. Influence of pretreatment with immunosuppressants on O-demethylation of dextromethorphan in isolated perfused rat liver. Experimental and Toxicologic Pathology 1999, 51 (4-5) , 330-334. https://doi.org/10.1016/S0940-2993(99)80016-5
63. Katy Kuo Korsmeyer, Suzanne Davoll, Maria Emilia Figueiredo-Pereira, Maria Almira Correia. Proteolytic Degradation of Heme-Modified Hepatic Cytochromes P450: A Role for Phosphorylation, Ubiquitination, and the 26S Proteasome?. Archives of Biochemistry and Biophysics 1999, 365 (1) , 31-44. https://doi.org/10.1006/abbi.1999.1138
64. Ali Bu-Abbas, Michael N. Clifford, Ron Walker, Costas Ioannides. Modulation of hepatic cytochrome P450 activity and carcinogen bioactivation by black and decaffeinated black tea. Environmental Toxicology and Pharmacology 1999, 7 (1) , 41-47. https://doi.org/10.1016/S1382-6689(98)00049-0
65. Alf H. Haukenes, Christine M. Moffitt. Concentrations of Erythromycin in Maturing Chinook Salmon after Intraperitoneal Injection of One of Two Drug Formulations. Journal of Aquatic Animal Health 1999, 11 (1) , 61-67. https://doi.org/10.1577/1548-8667(1999)011<0061:COEIMC>2.0.CO;2
66. P.E.B Reilly, S.R Mason, M.A Read. Human, rat and crocodile liver microsomal monooxygenase activities measured using diazepam and nifedipine: effects of CYP3A inhibitors and relationship to immunochemically detected CYP3A apoprotein. Comparative Biochemistry and Physiology Part C: Pharmacology, Toxicology and Endocrinology 1999, 122 (2) , 197-204. https://doi.org/10.1016/S0742-8413(98)10106-8
67. J. C. Gorski, D. R. Jones, M. A. Hamman, S. A. Wrighton, S. D. Hall. Biotransformation of alprazolam by members of the human cytochrome P4503A subfamily. Xenobiotica 1999, 29 (9) , 931-944. https://doi.org/10.1080/004982599238173
68. Brian G. Lake, Anthony B. Renwick, Morag E. Cunninghame, Roger J. Price, Dominic Surry, David C. Evans. Comparison of the effects of some CYP3A and other enzyme inducers on replicative DNA synthesis and cytochrome P450 isoforms in rat liver. Toxicology 1998, 131 (1) , 9-20. https://doi.org/10.1016/S0300-483X(98)00085-7
69. Matt J Cheesman, Paul E.B Reilly. Differential inducibility of specific mRNA corresponding to five CYP3A isoforms in female rat liver by RU486 and food deprivation. Biochemical Pharmacology 1998, 56 (4) , 473-481. https://doi.org/10.1016/S0006-2952(98)00163-4
70. Janice M. Huss, Charles B. Kasper. Nuclear Receptor Involvement in the Regulation of Rat Cytochrome P450 3A23 Expression. Journal of Biological Chemistry 1998, 273 (26) , 16155-16162. https://doi.org/10.1074/jbc.273.26.16155
71. Amaia Irizar, Costas Ioannides. Marked inhibition of hepatic cytochrome P450 activity in cholesterol-induced atherosclerosis in rabbits. Toxicology 1998, 126 (3) , 179-193. https://doi.org/10.1016/S0300-483X(98)00009-2
72. K. E. Thummel, G. R. Wilkinson. IN VITRO AND IN VIVO DRUG INTERACTIONS INVOLVING HUMAN CYP3A. Annual Review of Pharmacology and Toxicology 1998, 38 (1) , 389-430. https://doi.org/10.1146/annurev.pharmtox.38.1.389
73. G. SMITH, M. J. STUBBINS, L. W. HARRIES, C. R. WOLF. Molecular genetics of the human cytochrome P450 monooxygenase superfamily. Xenobiotica 1998, 28 (12) , 1129-1165. https://doi.org/10.1080/004982598238868
74. TERESA M. PEREIRA, JAN CARLSTEDT-DUKE, M. CELESTE LECHNER, JAN-ÅKE GUSTAFSSON. Identification of a Functional Glucocorticoid Response Element in the CYP3A1/IGC2 Gene. DNA and Cell Biology 1998, 17 (1) , 39-49. https://doi.org/10.1089/dna.1998.17.39
75. Kim J. Rich, Alan R. Boobis. Expression and inducibility of P450 enzymes during liver ontogeny. Microscopy Research and Technique 1997, 39 (5) , 424-435. https://doi.org/10.1002/(SICI)1097-0029(19971201)39:5<424::AID-JEMT5>3.0.CO;2-G
76. Randall S. Taylor, Steven M. Jones, Rolf H. Dahl, Mark H. Nordeen, Kathryn E. Howell. Characterization of the Golgi Complex Cleared of Proteins in Transit and Examination of Calcium Uptake Activities. Molecular Biology of the Cell 1997, 8 (10) , 1911-1931. https://doi.org/10.1091/mbc.8.10.1911
77. M Hebert. Contributions of hepatic and intestinal metabolism and P-glycoprotein to cyclosporine and tacrolimus oral drug delivery. Advanced Drug Delivery Reviews 1997, 27 (2-3) , 201-214. https://doi.org/10.1016/S0169-409X(97)00043-4
78. Buxiang Sun, Morio Fukuhara. Effects of co-administration of butylated hydroxytoluene, butylated hydroxyanisole and flavonoids on the activation of mutagens and drug-metabolizing enzymes in mice. Toxicology 1997, 122 (1-2) , 61-72. https://doi.org/10.1016/S0300-483X(97)00078-4
79. E. Sampol, A. Mirrione, P.H. Villard, P. Piccerelle, H. Scoma, P. Berbis, Y. Barra, A. Durand, B. Lacarelle. Evidence for a Tissue-Specific Induction of Cutaneous CYP2E1 by Dexamethasone. Biochemical and Biophysical Research Communications 1997, 235 (3) , 557-561. https://doi.org/10.1006/bbrc.1997.6829
80. Hindupur K Anandatheerthavarada, Sankar Addya, Radhey S Dwivedi, Gopa Biswas, Jayati Mullick, Narayan G Avadhani. Localization of Multiple Forms of Inducible Cytochromes P450 in Rat Liver Mitochondria: Immunological Characteristics and Patterns of Xenobiotic Substrate Metabolism. Archives of Biochemistry and Biophysics 1997, 339 (1) , 136-150. https://doi.org/10.1006/abbi.1996.9855
81. Nobumitsu Hanioka, Hideto Jinno, Tetsuji Nishimura, Masanori Ando. Effect of 2,4,4′-trichloro-2′-hydroxydiphenyl ether on cytochrome P450 enzymes in the rat liver. Chemosphere 1997, 34 (4) , 719-730. https://doi.org/10.1016/S0045-6535(97)00464-5
82. Angeliki P. Kourounakis, Eleni A. Rekka, Panos N. Kourounakis. Effect of Guaiazulene on Some Cytochrome P450 Activities. Implication in the Metabolic Activation and Hepatotoxicity of Paracetamol. Archiv der Pharmazie 1997, 330 (1-2) , 7-11. https://doi.org/10.1002/ardp.19973300103
83. L. Tantcheva, T. Stoytchev, D. Rangelova. Influence of hydrocortisone on the analgesic effect, toxicity and metabolism of aspirin in mice. General Pharmacology: The Vascular System 1997, 28 (1) , 123-128. https://doi.org/10.1016/S0306-3623(96)00080-8
84. Veena Puri, Krishan K. Kohli. Purification and Characterization of Dexamethasone Inducible Hepatic Cytochrome P450 Isozymes from Rhesus Monkey. Drug and Chemical Toxicology 1997, 20 (1-2) , 11-19. https://doi.org/10.3109/01480549709011075
85. M.R. Martinez-Larrañaga, A. Anadón, M.J. Diaz, R. Fernandez, B. Sevil, M.L. Fernandez-Cruz, M.C. Fernandez, M.A. Martinez, R. Anton. Induction of cytochrome P4501 A1 and P4504A1 activities andperoxisomal proliferation by furnonisin B1. Toxicology and Applied Pharmacology 1996, 141 (1) , 185-194. https://doi.org/10.1016/S0041-008X(96)80024-X
86. Lars W. Wormhoudt, Jan H.T.M. Ploemen, Isabelle de Waziers, Jan N.M. Commandeur, Philippe H. Beaune, Peter J. van Bladeren, Nico P.E. Vermeulen. Inter-individual variability in the oxidation of 1,2-dibromoethane: use of heterologously expressed human cytochrome P450 and human liver microsomes. Chemico-Biological Interactions 1996, 101 (3) , 175-192. https://doi.org/10.1016/0009-2797(96)03723-4
87. Shizuo Narimatsu, Masayuki Mochida, Takahiro Matsumoto, Yasuhiro Masubuchi, Toshiharu Horie, Kiyoshi Nagata, Yoshihiko Funae, Arthur K. Cho, Tokuji Suzuki. Cytochrome P450 enzymes involved in the enhancement of propranolol N-desisopropylation after repeated administration of propranolol in rats. Chemico-Biological Interactions 1996, 101 (3) , 207-224. https://doi.org/10.1016/0009-2797(96)03726-X
88. K KATO. Developmental expression of cytochrome p450s within intrasplenically transplanted fetal hepatocytes. Cell Transplantation 1996, 5 (5) , S27-S30. https://doi.org/10.1016/0963-6897(96)00035-8
89. J P McNamee, S M Kobus, G S Marks. The apoprotein of cytochrome P450 3A2 does not selectively direct alkylation to one of four pyrrole rings of N -vinylprotoporphyrin IX. Canadian Journal of Physiology and Pharmacology 1996, 74 (8) , 996-1000. https://doi.org/10.1139/y96-131
90. M Lekehal, D Pessayre, J M Lereau, C Moulis, I Fourasté, D Fau. Hepatotoxicity of the herbal medicine germander: Metabolic activation of its furano diterpenoids by cytochrome P450 3A Depletes cytoskeleton-associated protein thiols and forms plasma membrane blebs in rat hepatocytes. Hepatology 1996, 24 (1) , 212-218. https://doi.org/10.1002/hep.510240134
91. B. Sun, M. Fukuhara, T. Kinoshita, M. Kimura, F. Ushio. Differential induction of isozymes of drug-metabolizing enzymes by butylated hydroxytoluene in mice and Chinese hamsters. Food and Chemical Toxicology 1996, 34 (7) , 595-601. https://doi.org/10.1016/0278-6915(96)00020-8
92. M.J. Cheesman, S.R. Mason, P.E.B. Reilly. Effects of food deprivation and adrenalectomy on CYP3A induction by RU486 in female rats. The Journal of Steroid Biochemistry and Molecular Biology 1996, 58 (4) , 447-454. https://doi.org/10.1016/0960-0760(96)00063-5
93. Robert Martini, Michael Murray. Characterization of the in vivo inhibition of rat hepatic microsomal aldehyde dehydrogenase activity by metyrapone. Biochemical Pharmacology 1996, 51 (9) , 1187-1193. https://doi.org/10.1016/0006-2952(96)00054-8
94. Joanne Zurlo, Linda M. Arterburn. Characterization of a primary hepatocyte culture system for toxicological studies. In Vitro Cellular & Developmental Biology - Animal 1996, 32 (4) , 211-220. https://doi.org/10.1007/BF02722948
95. Alexandros N. Alexidis, Jan N.M. Commandeur, Eleni A. Rekka, Ed Groot, Panos N. Kourounakis, Nico P.E. Vermeulen. Novel piperidine derivatives: inhibitory properties towards cytochrome P450 isoforms, and cytoprotective and cytotoxic characteristics. Environmental Toxicology and Pharmacology 1996, 1 (1) , 81-88. https://doi.org/10.1016/1382-6689(95)00012-7
96. Maria Carelli, Maria Cabello Porras, Milena Rizzardini, Lavinia Cantoni. Modulation of constitutive and inducible hepatic cytochrome(s) P-450 by interferon β in mice. Journal of Hepatology 1996, 24 (2) , 230-237. https://doi.org/10.1016/S0168-8278(96)80034-1
97. David Kupfer. The Covalent Binding of Tamoxifen to Proteins and DNA. 1996, 201-230. https://doi.org/10.1007/978-1-4612-4092-1_9
98. David Kupfer, Shangara S. Dehal. [17] Tamoxifen metabolism by microsomal cytochrome P450 and flavin-containing monooxygenase. 1996, 152-163. https://doi.org/10.1016/S0076-6879(96)72019-0
99. R F Witkamp, S M Nijmeijer, A S van Miert. Cytochrome P-450 complex formation in rat liver by the antibiotic tiamulin. Antimicrobial Agents and Chemotherapy 1996, 40 (1) , 50-54. https://doi.org/10.1128/AAC.40.1.50
100. Kazuya Kato, W. John B. Hodgson, Nader G. Abraham, Kazhuiko Onodera, Masato Imai, Shinichi Kasai, Michio Mito. Expression and Inducibility of Cytochrome P450 Iiia Family within Intrasplenically Transplanted Fetal Hepatocytes. Cell Transplantation 1996, 5 (1) , 117-122. https://doi.org/10.1177/096368979600500116